{"record_key":"thermaquil-inc","identifier":"thermaquil-inc","external_key":"6DDF5D","title":"Thermaquil, Inc.","summary":null,"url":"https://inventions.pitt.edu/startups/thermaquil-inc","json_url":"https://inventions.pitt.edu/startups/thermaquil-inc.json","object_key":"startups","description":"Thermaquil is developing reversible, drug-free nerve-block devices for pain and conditions associated with overactive nerve signaling. Its thermal approach briefly warms a nerve and then cools it to sustain a block. University of Pittsburgh researcher Changfeng Tai and founding CEO Stephen Popielarski formed the company in 2017. [1]: https://engineering.pitt.edu/news/2025/the-evolution-of-thermaquil-inc/\nThe company’s research includes a wearable device targeting occipital nerves for severe head and neck pain, supported by a $1 million NSF SBIR Phase II award. Thermaquil also served as commercialization partner on a DARPA-funded collaboration with Tai’s laboratory investigating ways to restore bladder function after complete spinal cord injury. [2]: https://www.sbir.gov/awards/178165 [3]: https://www.innovation.pitt.edu/thermaquil_feature/","attributes":[{"key":"website","label":"Website","values":["https://www.thermaquil.com/"]},{"key":"sector","label":"Sector","values":["Medical Device"]},{"key":"therapeutic_areas","label":"Therapeutic Areas","values":["Neuroscience"]},{"key":"founders","label":"Founders","values":["Changfeng Tai","Stephen Popielarski"]}],"related":[]}